tetracycline resistance gene cartridge. Gene replacement techniques were used to introduce the mutated picS gene into the P. aeruginosa chromosome in place of the wild-type gene. The precise replacement of wild-type sequences by mutant sequences was confirmed by Southern hybridization. The mutant strain, designated PLC S, is nonhemolytic and lacks a 78-kilodalton protein corresponding to the size of the wild-type PLC. However, there is an additional phospholipase activity present in PLC S capable of hydrolyzing p-nitrophenylphosphorylcholine, a synthetic PLC substrate, and phosphatidylcholine. This enzymatic activity is not a result of a truncated product produced from the mutated pkcS gene. The phospholipase activity of PLC S was identified as a nonhemolytic PLC.
Pseudomonas aeruginosa is an important opportunistic pathogen that is a common cause of nosocomial infections. Lung infections with this pathogen are associated with high mortality rates in cystic fibrosis patients. Among the numerous extracellular products produced by P. aeruginosa which may contribute to pathogenesis, including toxins, proteases, and exopolysaccharides, are two hemolysins (13, 21) . One of these hemolysins is a heat-stable glycolipid. The other hemolysin is a heat-labile phospholipase C (PLC) which catalyzes the hydrolysis of phosphatidylcholine, yielding phosphorylcholine and diacylglycerol (7) . PLC may play an important role in the pathogenesis of lung infections (13) and may also be an important virulence determinant in other types of infections.
The PLC hemolysin produced by P. aeruginosa is synthesized maximally during the late log and early stationary phases of growth in low-phosphate media, but PLC synthesis is repressed in high-phosphate media (13) . PLC may enhance colonization of lung tissue by providing essential nutrients from the hydrolysis of phospholipids in surfactant (13) , which is composed primarily of phosphatidylcholine. Substrate specificity studies have shown that PLC preferentially hydrolyzes phospholipids containing quaternary ammonium groups, which are found primarily in eucaryotic membranes (e.g., phosphatidylcholine) but has little activity towards phospholipids found in the procaryotic membrane (4) .
The structural gene encoding PLC (plcS) has been cloned and sequenced (14, 22, 18) . plcS is part of a multigene operon which is regulated by Pi at the level of transcription (18) . The gene product ofplcS is an 82.6-kilodalton (kDa) protein. This protein contains a 4.4-kDa putative signal peptide which may be cleaved from the native PLC to yield the secreted 78.2-kDa mature hemolysin (18) . Downstream of pIcS are two in-phase overlapping genes designated p1cRi and plcR2 (19) . When expressed in Escherichia coli, a cytoplasmic form and a secreted form of the plcR gene products are observed (19 Ostroff and M. L. Vasil, Abstr. Annu. Meet. Am. Soc. Microbiol. 1986, Dlll, p. 90). To investigate the role of the PLC operon in pathogenesis and to better understand its regulation, an insertional mutation in plcS was constructed. Gene replacement techniques were used to introduce the mutated copy of the PLC operon into the chromosome in place of the wild-type operon in P. aeruginosa strain PAO1. The construction and analysis of the plcS mutant strain are described in this study.
MATERIALS AND METHODS
Materials. Phospholipids, p-nitrophenylphosphate, and pnitrophenylphosphorylcholine (NPPC) were obtained from Sigma Chemical Co., St. Louis, Mo. Restriction endonucleases and DNA modifying enzymes were purchased from Bethesda Research Laboratories, Bethesda, Md., and used as described by the supplier.
Bacterial strains and plasmids. The bacterial strains and plasmids used in these studies are listed in Table 1 .
Media and antibiotics. E. coli cultures were grown in brain heart infusion broth (Difco Laboratories) at 37°C. Tris minimal medium (20) or peptone medium (1% peptone, 1% NaCI) was used for production of PLC from P. aeruginosa with or without the addition of 10 mM Pi. Blood agar (5% sheep erythrocytes) (Pasco Labs, Wheatridge, Colo.) was used to screen hemolytic activity. Pseudomonas isolation agar (Difco) supplemented with the appropriate antibiotics was used to select for P. aeruginosa in the mating experiments. Antibiotics were used in the following concentrations (milligrams per liter): for E. coli, carbenicillin (200), tetracycline (20) , and trimethoprim (200); for P. aeruginosa, carbenicillin (1,000), tetracycline (200), and trimethoprim (1,000).
Transfer of plasmids from E. coli to P. aeruginosa. E. coli plasmid donor strains were grown in brain heart infusion broth with appropriate antibiotics overnight at 37°C. P. aeruginosa strains were grown at 43°C with aeration over- night and then incubated for 3 to 5 h without aeration at 43°C. A 3-ml amount of each culture was filtered onto a 0.45-,um Nalgene filter (diameter, 5.5 cm). The filters were placed on brain heart infusion broth plates at 30°C overnight. Cells were suspended in 5 ml of phosphate-buffered saline (80 mM NaCl, 43 mM Na2HPO4, 11 mM KH2PO4), diluted, and plated on pseudomonas isolation agar with the appropriate antibiotics.
Isolation and manipulation of DNA and Southern blot hybridization. Genomic DNAs of P. aeruginosa strains were prepared and digested as previously described (23). Southern blot hybridization and high-stringency washes were performed as previously described (23). Conditions for DNA purification and manipulation for cloning were as described before (15) .
Preparation of concentrated culture supernatants. Twoliter flasks were washed with chromic acid and then extensively rinsed with triple-distilled water to remove any trace of phosphate. Starter cultures were prepared from overnight cultures of P. aeruginosa strains grown in brain heart infusion broth. The cells were harvested by centrifugation and washed three times with Tris minimal medium before use as an inoculum. A 500-ml portion of Tris minimal medium with or without the addition of 10 mM Pi was inoculated to an A540 of 0.05. Cultures were grown overnight at 32°C. The cells were removed by centrifugation. Proteins in the supernatants were precipitated with ammonium sulfate to 70% saturation. The material was centrifuged at 15,000 x g for 30 min. The precipitated proteins from 500 ml of supernatant were dissolved in 5 ml of 10 mM Tris hydrochloride buffer (pH 7.2) and dialyzed against the same buffer overnight at 4°C. Samples used for hemolytic assays were dialyzed against phosphate-buffered saline overnight at 4°C. Protein concentrations for concentrated culture supernatants were determined by the method of Bradford (5), using a commercially prepared reagent (Bio-Rad Laboratories, Richmond, Calif.).
Hemolytic titers. Serial twofold dilutions of concentrated culture supernatants previously dialyzed against phosphatebuffered saline were added to 1% sheep erythrocytes. Hemolytic activity was estimated visually by determination of release of hemoglobin after 24 h of incubation at 37°C. Enzyme assays. PLC was measured by NPPC hydrolysis as previously described (12) or by the hydrolysis of phospholipids and the release of Pi (11) . The conditions for hydrolysis of phospholipids were as previously described (4) . The release of Pi was measured spectrophotometrically by the method of Chen et al. (6) .
RESULTS
Construction of an insertional mutation in pkcS. Plasmid pGV26 contains the cloned PLC operon within a 6.1-kilobase (kb) BamHI DNA fragment. This plasmid was identified from a P. aeruginosa BamHI genomic library by the hemolytic phenotype it conferred to E. coli HB101 (22) . The insertion of a tetracycline resistance (Tcr) cartridge into picS is shown in Fig. 1 . A 2.7-kb Tcr cartridge containing the tetAR locus from TnJO was isolated from TnS-132 by digesting ColEl::TnS-132 with BglII. The 5' protruding ends were filled in with Klenow fragment of DNA polymerase I and blunt end ligated into the single Stul site of pGV26, which is in the picS gene 504 nucleotides downstream from the starting codon. The resulting construct, pGM78, is nonhemolytic in E. coli.
The insertionally mutagenized PLC operon was used to construct a mutant P. aeruginosa strain isogenic with the wild-type strain, except at the pIcS locus. pGM78 was digested with BamHI, and the 8.9-kb fragment containing plc::tetAR was isolated and cloned into the BgllI site of pR751, resulting in pRR1 (Fig. 1) . pR751 is a large, lowcopy-number vector plasmid of the IncP-1 group. It is self-transmissible and capable of replicating in P. aeruginosa. pRR1 was mobilized into the prototrophic strain PA01. PAO1 containing pRR1 was grown without antibiotic selection for 146 h, and then cultures were diluted and plated on blood agar. Ten thousand colonies were examined for a nonhemolytic phenotype. The nonhemolytic phenotype is the result of inactivation of pIcS through homologous recombination between sequences on pRR1 and the PAO1 chromosome on either side of the Tcr insertion. Nonhemolytic Tcr clones were isolated at a frequency of 0.1%. Southern hybridization data confirmed that the wild-type plcS gene had been replaced by a single copy of the insertionally mutated pIcS sequences from pRR1 (data not shown). However, pRR1 was still present in these clones.
To eliminate pRR1, pME301 was mobilized into PA01 plc::tetAR(pRR1). pME301 is a plasmid which is a member of the same incompatibility group as pRR1, encodes Cbr, and is temperature sensitive for replication. By selection of Cbr, pRR1 was replaced by pME301. PA01 plc::tetAR was cured of pME301 by raising the temperature of the culture to 43°C, which is the nonpermissive temperature for pME301 replication. Tcr, CbS colonies were isolated. The resulting plasmid-free strain, designated PLC S, contains a chromosomal insertional mutation in plcS but is isogenic with PA01 at all other loci. PLC S is tetracycline resistant and nonhemolytic. It has no activity on egg yolk agar (lecithin agar), indicating that it is not capable of hydrolyzing lecithin (phosphatidylcholine) in this medium to release diacylglycerol (7).
Analysis of PLC S genomic DNA by Southern hybridization to PLC probes. Genomic DNAs from PA01 and PLC S were purified, digested with several restriction enzymes, and hybridized with the 6.1-kb BamHI-BamHI PLC probe in a Southern hybridization (Fig. 2) the size of the mature hemolytic PLC of P. aeruginosa is present in the PA01 sample but absent from the PLC S sample (data not shown).
Analysis of PA01 and PLC S culture supernatants. PLC S has no detectable hemolytic activity toward sheep erythrocytes ( Table 2 ). The hemolytic titer of the PA01 culture supernatant is increased 16-fold in low phosphate over the titer of the supernatant from growth in a high-Pi medium.
An unexpected characteristic of PLC S is that it retains PLC activity at a level only slightly less than that of PA01, as measured by the hydrolysis of the synthetic substrate NPPC (Table 2 ). This activity is Pi regulated and found extracellularly. It is also produced by PLC S at the same time during growth as the wild-type PLC activity (Fig. 3) . PLC activity can be detected in PA01 and PLC S culture supernatants after 4 h of growth, which corresponds to late logarithmic growth. This activity rises steadily through the early stationary phase of the culture.
Analysis of the phospholipase activity of PLC S. To confirm (Fig. 4) . The phospholipase activity from PLC S is only 30 to 50% of the level from PAO1, as measured by hydrolysis of phosphatidylcholine. The substrate specificity of the PLC S phospholipase is similar to that of PAO1. Both PA01 and PLC S hydrolyze phosphatidylcholine but have little activity towards phosphatidylethanolamine.
To identify the type of phospholipase activity present in the PLC S supernatant, thin-layer chromatography with 3H-and '4C-labeled phosphatidylcholine was used. The reaction products after cleavage of phosphatidylcholine by both PA01 and PLC S were diacylglycerol, phosphorylcholine, and choline (data not shown). The generation of diacylglycerol and phosphorylcholine from phosphatidylcholine confirms the existence of a PLC produced by PLC S.
The choline is generated from release of Pi from phosphorylcholine by alkaline phosphatase in the concentrated culture supernatants. The hydrolysis of phosphatidylcholine by both strains was Pi regulated. and M. L. Vasil, unpublished observation). The nonhemolytic PLC shares a similar substrate specificity with the hemolytic PLC encoded by picS. Both enzymes hydrolyze phospholipids with quaternary ammonium groups, such as phosphatidylcholine, which is abundant in the eucaryotic cell membrane (1), and have little activity towards phosphatidylethanolamine, a phospholipid found primarily in the procaryotic membrane (1) .
However, the PLC produced by PLC S hydrolyzes phosphatidylcholine at only 30 to 50% of the level of the parental strain. These results may explain why this PLC is nonhemolytic. Perhaps this second PLC does not efficiently attack phospholipids which are assembled into a membranetype structure, but can easily cleave small molecules such as NPPC or solubilized phospholipids. The PLC produced by Bacillus cereus is nonhemolytic to intact erythrocytes (17) . However, it can hydrolyze a broad spectrum of phospholipids in in vitro assays in which the phospholipids are detergent solubilized (17) . Perhaps the second PLC of P. aeruginosa is nonhemolytic because the phospholipids of the eucaryotic membrane are not accessible to this enzyme. However, more careful investigation is required before this hypothesis can be confirmed.
The mutation in the picS gene does not markedly affect the production of other extracellular Pi-regulated proteins examined thus far. The picS insertional mutation contains a transcriptional terminator (8) and would be expected to produce polar effects on the downstreamn genes of the PLC operon, picRI and plcR2, and reduce their expression. However, the function of the gene products of picRi and plcR2 is not known, and polar effects may occur which have not been identified. The PLC S mutant strain will be useful in establishing the role of the hemolytic PLC in pathogenesis by comparing the virulence of PLC S to the wild-type strain in various animal models of infection. It is also possible to use gene replacement techniques to transfer the mutant picS to other clinically relevant P. aeruginosa strains for use in pathogenesis studies. Additional molecular and biochemical studies of the two PLCs of P. aeruginosa will help in understanding the structure-function relationship of hemolytic versus nonhemolytic PLC activity. Finally, further investigation into the synthesis and regulation of the nonhemolytic PLC-may answer some questions about the complex physiology of Pi regulation in P. aeruginosa.
